ep-101
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2011 (NCT01426009)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Receptor protein-tyrosine kinase erbB-2Immunity, active
ERBB2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ep-101
- ep-101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01706536 | Phase 2 | Oct 1, 2012 | Sunovion |
| NCT01426009 | Phase 2 | Aug 1, 2011 | Elevation Pharmaceuticals, Inc., Sunovion |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sunovion | For profit | 2 | 2 | 1 | 2011 |
| Elevation Pharmaceuticals, Inc. | For profit | 1 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1